Purchase Order 75N93024P00345
Award Date 2/15/24
Potential Completion Date 2/14/25
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc., was issued by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) Office of Acquisitions. The $26,949.12 firm fixed price purchase order does not have a set-aside designation. The contract is for the delivery of laboratory equipment, reagents, and consumables to support biomedical research and testing. Bio-Rad...
- Bio-Rad Laboratories, Inc. Life Science Group Division has been awarded a firm fixed price purchase order totaling $15,260 by the Department of Health and Human Services' National Institutes of Health Clinical Center. The contract has no set-aside designation and calls for Bio-Rad to provide unspecified products or services with a period of performance through March 1, 2024. This award is associated with a pre-existing $1 billion blanket purchase agreement between Bio-Rad and the NIH that...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division valued at $149,999.00. The contract is for the delivery of a BIO-RAD S3E CELL SORTER 488/640-2L4D to support biomedical research at the agency's facilities in Hercules, California. Bio-Rad Laboratories, a leading manufacturer of life science research products and clinical...
- This contract was awarded by the National Institutes of Health (NIH) to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of the publicly traded life sciences company Bio-Rad Laboratories, Inc. The $22,853.96 firm-fixed-price purchase order does not have a set-aside designation. It provides for the delivery of various biological research products and associated maintenance services to the NIH. Bio-Rad Laboratories, Inc. holds a $1 billion Blanket Purchase Agreement with the...
- Bio-Rad Laboratories, Inc. Life Science Group Division has been awarded a $16,085.40 firm-fixed-price purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to provide maintenance services in Bethesda, Maryland. The period of performance is through February 28, 2027. This award is not associated with any set-aside designation. Bio-Rad Laboratories holds a five-year, one billion dollar blanket purchase agreement with the Department...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Bio-Rad Laboratories, Inc. Life Science Group Division, a subsidiary of Bio-Rad Laboratories, Inc. The contract is for the procurement of a Bio-Plex 100/200 System and 1 year of full on-site complete support. The potential value of the contract is $15,806.00. The contract does not have a set-aside...
- Bio-Rad Laboratories, Inc.'s Life Science Group Division has been awarded a $30,298.80 firm fixed-price purchase order by the National Institutes of Health Clinical Center, with an ultimate completion date of January 22, 2027. The contract, which was not subject to small business set-aside designation, was awarded on January 23, 2026, and will be performed at Bio-Rad's facility in Hercules, California. As a global leader in life science research and clinical diagnostics, Bio-Rad will supply...
- Bio-Rad Laboratories, Inc. was awarded a firm fixed-price purchase order valued at $34,575.59 by the National Institutes of Health Office of Logistics and Acquisition Operations on May 1, 2026, with an ultimate completion date of August 1, 2026. This contract award carries no small business set-aside designation. The award represents a task order placed against Bio-Rad's existing $10 million Blanket Purchase Agreement with NIH, which became effective December 18, 2023, and remains valid...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $4,613.30 firm fixed price purchase order to Bio-Rad Laboratories, Inc. Life Science Group Division for service agreements on a ChemiDoc system and Bio-Plex 200 instrument. This contract is not associated with a set-aside designation. Bio-Rad Laboratories, Inc. is a global leader in developing and manufacturing life science research and clinical diagnostics...
- This federal contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Bio-Rad Laboratories, Inc. The $7,404.00 firm fixed-price purchase order is for the delivery of various laboratory products and services related to biomedical research and testing. Bio-Rad is a global leader in developing and manufacturing life science research and clinical diagnostics products, including real-time PCR systems, thermal cyclers, gel imaging...
Bio-Rad Laboratories, Inc. Life Science Group Division was awarded a firm fixed price purchase order totaling $10,188 for annual on-site service and support of Bioplex 100/200 system equipment in support of the National Institutes of Health National Institute of Allergy and Infectious Diseases. No set-aside designation was specified. This contract was awarded under the Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations blanket purchase agreement valued at up to $1 billion, which allows for efficient procurement of laboratory resources to sustain NIH's medical research mission through 2024.
Generated 2/15/24, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 2/14/24 |